Skip to main content
SpringerLink
Log in

Liver tumor promotion: Effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-β1 expression

  • Conference Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Phenobarbital (PB) added to the medium of cultured rat hepatocytes alters epidermal growth factor (EGF) dependent mitogenesis in a biphasic manner; PB concentrations<1.5 mM are growth stimulatory but higher concentrations significantly inhibit normal hepatocyte proliferation. In contrast, the growth of putative preneoplastic cells is inhibited less by high concentrations of PB. Mechanistic studies designed to test the ability of PB to alter the early events of EGF signal transduction demonstrate that PB neither competes with EGF for binding to the EGF receptor nor alters EGF-induced receptor down-regulation. However, pretreatment with PB (>1 mM) results in a transient inhibition of EGF binding to hepatocytes. The kinetics of this effect are similar to those obtained when hepatocytes are exposed to the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), a skin tumor promoter and activator of Ca2+/phospholipid-dependent protein kinase C. However, several observations suggest that distinct mechanisms mediate the responses to these two tumor promoters. First, the inhibitory effects of PB and TPA on EGF binding are additive. Also down-regulation of EGF receptors in response to TPA occurs with hepatocytes, A431 epidermal carcinoma cells, HepG2 hepatoma cells, and rat liver epithelial cells, but only hepatocytes are sensitive to PB. Furthermore, translocation of protein kinase C to the membrane occurs in hepatocytes treated with TPA but not in those treated with PB. The chronic treatment of rats with PB further sensitizes hepatocytes to EGF receptor downregulation by inin vitro PB while desensitizing them to EGF receptor down-regulation by TPA. This latter effect is correlated with a decreased ability of TPA to induce translocation of protein kinase C to the membrane. PB significantly increases the intracellular concentration of TGF-β1 in periportal hepatocytes but not in putative preneoplastic cells. TGF-β1 may therefore have an important function in regulating early stages of cell cycle progression in proliferating hepatocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Peraino C, Fry RJM, Staffeldt E: Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res 31:1506–1512, 1971

    Google Scholar 

  2. Peraino C, Fry RJM, Staffeldt E, Christopher JP: Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res 35:2884–2890, 1975

    Google Scholar 

  3. Preat V, Lans M, de Gerlache J, Taper H, Roberfroid M: Influence of the duration and the delay of administration of phenobarbital on its modulating effect on rat hepatocarcinogenesis. Carcinogenesis 8:333–335, 1987

    Google Scholar 

  4. Argyris RS: Stimulators, enzyme induction and the control of liver growth.In Control of Proliferation in Animal Cells. B Clarkson, R Baserga (eds). Cold Spring Harbor, New York, Cold Spring Harbor Conference on Cell Proliferation, 1974, pp 49–66

  5. Yager JD, Roebuck BD, Paluszcyk TL, Memoli VA: Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. Carcinogenesis 7:2007–2014, 1986

    Google Scholar 

  6. Jirtle RL, Michalopoulos G: Enhancement of the clonability of adult parenchymal hepatocytes with the liver tumor promoter phenobarbital. Carcinogenesis 7:1813–1817, 1986

    Google Scholar 

  7. Eckl PM, Meyer SA, Whitcombe WR, Jirtle RL: Phenobarbital reduces EGF receptors and the ability of physiological concentrations of calcium to suppress hepatocyte proliferation. Carcinogenesis 9:479–483, 1988

    Google Scholar 

  8. Gupta C, Hattori A, Betschart JM, Virji MA, Shinozuka H: Modulation of epidermal growth factor receptors in rat hepatocytes by two liver tumor-promoting regimens, a choline-deficient and phenobarbital diet. Cancer Res 48:1162–1165, 1988

    Google Scholar 

  9. Hsieh LL, Peraino C, Weinstein IB: Expression of endogenous retrovirus-like sequences and cellular oncogenes during phenobarbital treatment and regeneration in rat liver. Cancer Res 48:265–269, 1988

    Google Scholar 

  10. Barbason H, Rassenfosse C, Betz EH: Promotion mechanism of phenobarbital and partial hepatectomy in DENA hepatocarcinogenesis cell kinetics effect. Br J Cancer 47:517–525, 1983

    Google Scholar 

  11. Evarts RP, Marsden ER, Thorgeirsson SS: Modulation of asialoglycoprotein receptor levels in rat liver by phenobarbital treatment. Carcinogenesis 6:1767–1773, 1985

    Google Scholar 

  12. Betschart JM, Virji MA, Gupta C, Shinozuka H: Alterations induced by phenobarbital, a liver tumor promoter, in hepatocyte receptors for insulin and glucagon and glycogen metabolism. Carcinogenesis 9:1289–1294, 1988

    Google Scholar 

  13. Marti U, Burwen SJ, Jones AL: Biological effects of epidermal growth factor with emphasis on the gastrointestinal tract and liver: An update. Hepatology, 9:126–138, 1989

    Google Scholar 

  14. Meyer SA, Jirtle RL: Phenobarbital decreases hepatocyte EGF receptor expression independent of protein kinase C activation. Biochem Biophys Res Commun 158:652–659, 1989

    Google Scholar 

  15. Meyer SA, Gibbs TA, Jirtle RL: Independent mechanisms for tumor promoters phenobarbital and 12-0-tetradecanoylphorbol-13-acetate in reduction of epidermal growth factor binding by rat hepatocytes. Cancer Res 49:5907–5912, 1989

    Google Scholar 

  16. Thompson NL, Flanders KC, Smith JM, Ellingsworth LR, Roberts AB, Sporn MB: Expression of transforming growth factor-betal in specific cells and tissues of adult and neonatal mice. J Cell Biol 108:661–669, 1989

    Google Scholar 

  17. Rotstein J, Sarma DSR, Farber E: Sequential alterations in growth control and cell dynamics of rat hepatocytes in early precancerous steps in hepatocarcinogenesis. Cancer Res 46:2377–2385, 1986

    Google Scholar 

  18. Rabes HM, Szymkowiak R: Cell kinetics of hepatocytes during the preneoplastic period of diethylnitrosamineinduced liver carcinogenesis. Cancer Res 39:1298–1304, 1979

    Google Scholar 

  19. Schulte-Hermann R, Ohde G, Schuppler J, Timmermann-Trosiener I: Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin. Cancer Res 41:2556–2562, 1981

    Google Scholar 

  20. Pugh TD, Goldfarb S: Quantitative histochemical and autoradiographic studies of hepatocarcinogenesis in rats fed 2-acetylaminofluorene followed by phenobarbital. Cancer Res 38:4450–4457, 1978

    Google Scholar 

  21. Becker FF, Klein KM: The effect ofl-asparaginase on mitotic activity duringN-fluorenylacetamide hepatocarcinogenesis: Subpopulations of nodular cells. Cancer Res 31:169–173, 1971

    Google Scholar 

  22. Edwards AM, Lucas CM: Phenobarbital and some other liver tumor promoters stimulate DNA synthesis in cultured rat hepatocytes. Biochem Biophys Res Commun 131:103–108, 1985

    Google Scholar 

  23. Sawada N, Staecker JL, Pitot HC: Effects of tumorpromoting agents 12-O-tetradecanoylphorbol-13-acetate and phenobarbital on DNA synthesis of rat hepatocytes in primary cultures. Cancer Res 47:5665–5671, 1987

    Google Scholar 

  24. Armato U, Andreis PG, Ramano F: The stimulation by the tumour promoters 12-O-tetradecanoyl-phorbol-13-acetate and phenobarbital of the growth of primary neonatal hepatocytes. Carcinogenesis 60:811–822, 1985

    Google Scholar 

  25. Miyazaki M, Handa Y, Oda M, Yabe T, Miyano K, Sato J: Long-term survival of functional hepatocytes from adult rat in the presence of phenobarbital in primary culture. Exp Cell Res. 159:176–190, 1985

    Google Scholar 

  26. Kitagawa T, Kayano T, Mikami K, Watanabe R, Sugano H: Promotion of hepatocarcinogenesisin vivo andin vitro.In Cellular Interactions by Environmental Tumor Promoters. H Fujiki, E Hecker, RE Moore, T Sugimura, IB Weinstein (eds). Tokyo, Science Society Press, 1984, pp. 337–348

    Google Scholar 

  27. Kaufmann WK, Ririe DG, Kaufman DG: Phenobarbital-dependent proliferation of putative initiated rat hepatocytes. Carcinogenesis 9:779–782, 1988

    Google Scholar 

  28. Solt D, Farber E: New principal for the analysis of chemical carcinogenesis. Nature 263:701–703, 1976

    Google Scholar 

  29. Laconi E, Li F, Semple E, Rao PM, Rajalakshini S, Sarma DSR: Inhibition of DNA synthesis in primary cultures of hepatocytes by orotic acid. Carcinogenesis 9:675–677, 1988

    Google Scholar 

  30. Magun BE, Bowden GT: Effects of phorbol ester promoters on the binding, processing, and biological activity of epidermal growth factor.In Mechanisms of Tumor Promotion, Vol. III. TJ Slaga (ed). Boca Raton, Florida, CRC Press, 1984, pp. 125–141

    Google Scholar 

  31. Cochet C, Gill GN, Meisenhelder J, Cooper JA, Hunter T: C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem 259:2553–2558, 1984

    Google Scholar 

  32. Iwashita S, Fox CF: Epidermal growth factor and potent phorbol tumor promoters induce epidermal growth factor receptor phosphorylation in a similar but distinctly different manner in human epidermoid carcinoma A431 cells. J Biol Chem 259:2559–2567, 1984

    Google Scholar 

  33. Davis RJ, Czech MP: Tumor-promoting phorbol diesters mediate phorphorylation of the epidermal growth factor receptor. J Biol Chem 259:8545–8549, 1984

    Google Scholar 

  34. Thomas TP, Gopalakrishna R, Anderson WB: Hormone-and tumor promoter-induced activation or membrane association of protein kinase C in intact cells. Methods Enzymol 141:399–411, 1987

    Google Scholar 

  35. Fujiki H, Sugimura T: New classes of tumor promoters: Teleocidin, aplysiatoxin, and palytoxin. Adv Cancer Res 49:223–264, 1987

    Google Scholar 

  36. Wattenberg EV, Fujiki H, Rosner MR: Heterologous regulation of the epidermal growth factor receptor by palytoxin, a non-12-O-tetradecanoylphorbol-13-acetate-type tumor promoter. Cancer Res 47:4618–4622, 1987

    Google Scholar 

  37. Suganuma M, Fujiki H, Suguri H, Yoshizawa S, Hirota M, Nakayasu M, Ojika M, Wakamatsu K, Yamada K, Sugimura T: Okadaic acid: An additional non-phorbol 12-tetradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 85:1768–1771, 1988

    Google Scholar 

  38. Meyer SA, Brockenbrough JS, Gibbs TA, Jirtle RL: Downregulation of hepatocyte EGF receptors by phenobarbital is mediated through a protein kinase C-independent mechanism. Proc Am Assoc Cancer Res 30:211, 1989

    Google Scholar 

  39. Sahyoun N, Wolf M, Bestermann J, Hsieh T, Sander M, Leviene H III, Chang KJ, Cuatracasas P: Protein kinase C phosphorylates topoisomerase II: Topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells. Proc Natl Acad Sci USA 83:1603–1607, 1986

    Google Scholar 

  40. Imagawa M, Chiu R, Karin M: Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP. Cell 51:257–260, 1987

    Google Scholar 

  41. McCaffrey P, Ran W, Campisi J, Rosner MR: Two independent growth factor-generated signals regulate c-fos and c-myc mRNA levels in Swiss 3T3 cells. J Biol Chem 262:1442–1445, 1987

    Google Scholar 

  42. Roberts AB, Sporn MB: Transforming growth factor beta. Adv Cancer Res 51:107–145, 1988

    Google Scholar 

  43. Strain AJ, Frozen A, Hill DJ, Milner RDG: Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem Biophys Res Commun 145:436–442, 1987

    Google Scholar 

  44. McMahon JB, Richards WL, del Campo AA, Song M-KH, Thorgeirsson SS: Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res 40:4665–4671, 1986

    Google Scholar 

  45. Russell WE, Coffey RJ Jr, Ovellette AJ, Moses HL: Type B transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 85:5126–6130, 1988

    Google Scholar 

  46. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N: Transforming growth factor β mRNA increases during liver regeneration: A possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 85:1539–1543, 1988

    Google Scholar 

  47. Flanders KC, Thompson NL, Cissel DS, van Obberghen-Schilling E, Baker CC, Kass ME, Ellingsworth LR, Roberts AB, Sporn MB: Transforming growth factor β1: Histochemical localization with antibodies to different epitopes. J Cell Biol 108:653–660, 1989

    Google Scholar 

  48. Caffey RJ, Kost LJ, Lyons RM, Moses HL, LaRusso NF: Hepatic processing of transforming growth factor β in the rat. Uptake, metabolism, and biliary excretion. J Clin Invest 80:750–757, 1987

    Google Scholar 

  49. Grisham JW: Cellular proliferation in the liver.In Normal and Malignant Cell Growth. RJM Fry, ML Griem, WH Kirsten (eds). New York, Springer-Verlag, 1969, pp 28–43

    Google Scholar 

  50. Lanier TL, Berger EK, Eacho PI: Comparison of 5-bromo-2-deoxyuridine and [3H]thymidine for studies of hepatocellular proliferation in rodents. Carcinogenesis 10:1341–1343, 1989

    Google Scholar 

  51. Schulte-Hermann R, Timmermann-Trosiener I, Schuppler J: Facilitated expression of adaptive responses to phenobarbital in putative pre-stages of liver cancer. Carcinogenesis 7:1651–1655, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Radiation Oncology, Department of Radiology, Duke University Medical Center, Box 3433, 27710, Durham, North Carolina

    Randy L. Jirtle PhD & Sharon A. Meyer PhD

Authors
  1. Randy L. Jirtle PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharon A. Meyer PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jirtle, R.L., Meyer, S.A. Liver tumor promotion: Effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-β1 expression. Digest Dis Sci 36, 659–668 (1991). https://doi.org/10.1007/BF01297035

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01297035

Key Words

Search

Navigation